Related Experiment Videos
Intravenous gammaglobulin treatment for thrombocytopenia associated with infectious diseases
American Journal of Hematology
|October 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Twenty-year survival of advanced gastrointestinal stromal tumours treated with imatinib: exploratory long-term follow-up of the BFR14 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Reactive oxygen species and aldehyde dehydrogenase 1A as prognosis and theragnostic biomarker in acute myeloid leukaemia patients.
Journal of cellular and molecular medicine·2024
A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Improved nationwide survival of sarcoma patients with a network of reference centers.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
A Pooled CRISPR Screen Reveals Genes Critical for Erythroblast Enucleation.
American journal of hematology·2026
Cerebral Small Vessel Disease in Immune-Mediated Thrombotic Thrombocytopenic Purpura Patients During the Acute Phase and Disease Remission.
American journal of hematology·2026
Hairy Cell Leukemia: 2026 Update on Diagnosis, Risk-Stratification, and Treatment.
American journal of hematology·2026
Checkpoint inhibitors and chronic comedications: A retrospective study on immune-related adverse events.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026
IgG4-related kidney disease: treatment standard.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Programmable Immunity: DNA Nanostructures in Cancer Immunotherapy.
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026